Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Click Therapeutics develops software as a medical treatment prescription platform designed to deliver digital treatments for patients.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Sanofi Ventures has invested in 72 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi Ventures's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Dice Therapeutics received $345.0M in a Post-IPO Equity round. Sanofi Ventures's total known invested capital is $3.6B.
Sanofi Ventures's average investment size is $71.3M across its portfolio of 72 companies.
Recent Sanofi Ventures portfolio additions include i2o Therapeutics, Tisento Therapeutics, OMass Therapeutics, Muna Therapeutics, Atalanta Therapeutics. These companies were founded in 2020 or later.